查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球無菌測試市場：按產品,測試,應用,最終用戶和地區劃分的未來預測（至 2028 年）
市場調查報告書
商品編碼
1241252

全球無菌測試市場：按產品,測試,應用,最終用戶和地區劃分的未來預測（至 2028 年）

Sterility Testing Market by Product, Test, Application, End User & Region - Global Forecasts to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 192 Pages | 訂單完成後即時交付

價格
簡介目錄

全球無菌檢測市場預計將從2023年的11億美元增長到2028年的19億美元，CARG為10.5%。

製藥和生物技術產能增加,新型生物製藥研發增加以及生命科學研究投資增加等因素預計將推動市場增長。 另一方面，一次性技術的普及和產品審批的嚴格監管準則預計將在一定程度上抑制市場增長。

“按產品/服務分類，試劑盒和試劑在預測期內增長最快”

通過按產品/服務查看無菌檢測市場，預計試劑盒和試劑部分將成為預測期內（2023 年至 2028 年）增長最快的部分。 由於易於使用，這些試劑盒廣泛用於製藥和生物技術行業。 此外，較長的保留期導致教育機構和 CRO 的採用率增加。 無菌檢測在藥物和生物製藥的臨床和商業生產中必不可少。 製藥和生物技術公司正在採用試劑盒和試劑進行無菌檢測，因為它們具有成本效益和時間效率。

“按應用劃分，2022 年製藥和生物製品領域的市場份額最大”

通過按應用查看無菌檢測市場，製藥和生物製品製造領域將在 2022 年佔據最大份額。 這一領域的增長是由全球製藥和生物製品產能擴張推動的。

“按地區劃分，北美在 2022 年佔據了最大的地區份額”

到 2022 年，北美將按地區主導滅菌檢測市場。 該地區是主要製藥和生物製藥公司製造設施的所在地，預計將有助於滿足北美對無菌檢測的巨大需求。 此外，隨著藥品批准率的提高，無菌檢測市場有望擴大。 由於疾病的傳播和患者數量的增加，北美對藥品和生物製藥的需求正在增加。 此外，北美的製藥和生物技術行業在研發方面投入巨大，預計在未來幾年內將快速增長。

在這份報告中，我們分析了全球無菌檢測市場，包括市場的基本結構,最新發展,驅動和抑制市場的主要因素，以及產品/服務的類型,測試類型,應用,終端-用戶，我們正在按地區調查市場趨勢的前景,市場競爭狀況以及主要公司的概況。

內容

第一章介紹

第二章研究方法論

第 3 章執行摘要

第 4 章重要注意事項

第 5 章市場概述

  • 介紹
  • 市場動態
    • 司機
    • 約束因素
    • 機會
    • 任務
  • 關稅和法規
  • 波特的五力分析
  • 供應鏈分析
  • 技術分析
  • 參考價格
  • 專利分析
  • 生態系統分析
  • 主要會議和活動 (2023-2024)
  • 主要利益相關者和採購標準
  • 貿易分析

第 6 章無菌檢測市場：按產品/服務分類

  • 介紹
  • 試劑盒和試劑
  • 服務
  • 設備

第 7 章無菌檢測市場：按檢測類型分類

  • 介紹
  • 膜過濾
  • 直接接種
  • 其他類型的測試

第 8 章無菌檢測市場：按應用

  • 介紹
  • 藥物和生物製品的製造
  • 醫療設備製造
  • 其他用途

第 9 章無菌檢測市場：按最終用戶分類

  • 介紹
  • 製藥公司
  • 生物技術公司
  • 其他最終用戶

第 10 章無菌檢測市場：按地區

  • 介紹
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲國家
  • 亞洲
    • 中國
    • 日本
    • 印度
    • 韓國
    • 其他亞洲國家
  • 其他國家（行）
    • 拉丁美洲/加勒比地區
    • 太平洋和大洋洲
    • 非洲

第11章競爭格局

  • 概覽
  • 主要公司採用的策略
  • 市場份額分析
  • 主要公司的收入份額分析
  • 公司評估象限
  • 商業評估象限：初創公司/中小企業
  • 競爭基準
    • 公司產品足跡
    • 公司的地理足跡
  • 競爭場景

第12章公司簡介

  • 主要公司
    • MERCK KGAA
    • CHARLES RIVER LABORATORIES
    • BIOMERIEUX SA
    • SGS S.A.
    • SARTORIUS AG
    • THERMO FISHER SCIENTIFIC INC.
    • WUXI APPTEC
    • SAMSUNG BIOLOGICS
    • GENSCRIPT
    • PACIFIC BIOLABS
    • NELSON LABORATORIES, LLC
  • 其他企業
    • PACE ANALYTICAL
    • RAPID MICRO BIOSYSTEMS, INC.
    • TENTAMUS
    • SINGOTA SOLUTIONS
    • NEOPHARM LABS INC.
    • LEXAMED
    • ASTELL SCIENTIFIC LTD
    • HIMEDIA LABORATORIES
    • PALL CORPORATION (PART OF DANAHER CORPORATION)
    • BOSTON ANALYTICAL
    • SOLVIAS AG
    • BD

第13章 附錄

簡介目錄
Product Code: BT 5095

The global sterility testing market is expected to reach USD 1.9 billion in 2028 from USD 1.1 billion in 2023 at a CARG of 10.5%. Factors such as expanding pharmaceutical & biotechnology production capacities, increasing development of novel biopharmaceutical products, and rising investments in life sciences research are expected to drive market growth. However, the growing adoption of single-use technology and stringent regulatory guidelines for product approval are expected to restrain market growth to a certain extent.

"During the forecast period, the kits & reagent is expected to account as the fastest-growing segment ."

Based on product & service, the sterility testing market is divided into kits & reagents, instruments, and services. During the forecast period (2023-2028), the kits & reagents segment is also expected to be the fastest-growing segment in the sterility testing market. Kits are widely used in the pharmaceutical and biotechnology industries as it is easy to use. Moreover, the long shelf life of these products is contributing to their rising adoption in academic institutions and contract research organizations. Sterility testing is mandatory during the clinical and commercial manufacturing of pharmaceutical & biopharmaceutical products. Pharmaceutical & biotechnology companies adopt kits & reagents for sterility testing as it is cost-effective and time-efficient.

"In 2022, by application segment, pharmaceutical & biologics accounted for the biggest market share"

Based on application, the sterility testing market is divided into pharmaceutical & biologics manufacturing, medical device manufacturing, and other applications. In 2022, the pharmaceutical and biologics manufacturing segment accounted for the largest share of the application segment in the sterility testing market. Factors responsible for the growth in this segment include the growing, growing pharmaceutical and biopharmaceutical production capacity across the globe.

"In 2022, North America accounted for the largest regional share in this market"

The market for sterility testing was dominated by North America in 2022. Presence of manufacturing facilities of major pharmaceutical and biopharmaceutical firms in the region will contribute for the huge demand for sterility testing in North America. The market for sterility testing is anticipated to grow in the region as drug approval rates rise. Also, the demand for pharmaceuticals and biopharmaceuticals in North America are rising due to the rising prevalence of diseases and the expanding patient population. Moreover, the pharmaceutical and biotechnology sectors in North America make substantial R&D investments and are anticipated to experience rapid growth in the coming years.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Respondent- Supply Side- 70%, Demand Side-30%
  • By Designation- CXOs and Directors- 30%, Executives - 25%, Mangers - 45%
  • By Region- North America - 40%, Europe - 25%, APAC - 20%, RoW- 15%

The sterility testing market is dominated by a few globally established players such as Charles River Laboratories (US), Merck KGaA (Germany), bioMerieux SA (France), SGS SA (Switzerland), WuXi AppTec (China), Nelson Laboratories, LLC (US), Pacific BioLabs (US), Sartorius AG (Germany), Thermofisher Scientific Inc. (US), and Samsung Biologics (South Korea). The study includes an in-depth competitive analysis of these key players in the sterility testing market with their company profiles, recent developments, and key market strategies.

Research Coverage:

The report segments the sterility testing market based on region (North America, Europe, Asia, and Rest of the World), by product & service (kits & reagents, instruments, and services), by test type (membrane filtration, direct inoculation, and other tests), by application (pharmaceuticals and biologicals, medical devices, and other applications), and by end user (pharmaceutical companies, biotechnology companies, and others ). The report also provides a comprehensive review of market drivers, restraints opportunities, challenges and trends in the sterility testing market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the sterility testing market and provides them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Primary sources
      • 2.1.2.3 Breakdown of primaries
    • FIGURE 2 STERILITY TESTING MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 STERILITY TESTING MARKET SIZE ESTIMATION (2022)
    • FIGURE 4 STERILITY TESTING MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
    • FIGURE 5 KEY INDUSTRY INSIGHTS
    • FIGURE 6 STERILITY TESTING MARKET: CAGR PROJECTION (2023-2028)
    • FIGURE 7 STERILITY TESTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH LIMITATIONS
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 RECESSION IMPACT
    • TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY

    • FIGURE 9 STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 STERILITY TESTING MARKET, BY TEST TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 STERILITY TESTING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 STERILITY TESTING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 STERILITY TESTING MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 STERILITY TESTING MARKET OVERVIEW
    • FIGURE 14 RISING EXPANSION OF PHARMACEUTICAL & BIOPHARMACEUTICAL PRODUCTION CAPACITIES TO FUEL UPTAKE OF STERILITY TESTING SERVICES
  • 4.2 ASIA: STERILITY TESTING MARKET, BY PRODUCT & COUNTRY (2022)
    • FIGURE 15 KITS & REAGENTS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN CHINA
  • 4.3 STERILITY TESTING MARKET, BY REGION (2022)
    • FIGURE 16 ASIA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 STERILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising expansion of pharmaceutical & biopharmaceutical production capacities
      • 5.2.1.2 Increasing development of novel biopharmaceutical products
    • TABLE 2 NOVEL DRUG APPROVALS (2022)
      • 5.2.1.3 Rising investments in life sciences research
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Growing adoption of single-use technology
      • 5.2.2.2 Stringent regulatory guidelines for product approval
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
      • 5.2.3.2 Increasing outsourcing of services to sterility testing providers
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled professionals
  • 5.3 TARIF AND REGULATION
    • 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 STERILITY TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1 THREAT FROM NEW ENTRANTS
    • 5.4.2 THREAT FROM SUBSTITUTES
    • 5.4.3 BARGAINING POWER OF BUYERS
    • 5.4.4 BARGAINING POWER OF SUPPLIERS
    • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 18 STERILITY TESTING MARKET: SUPPLY CHAIN ANALYSIS
  • 5.6 TECHNOLOGICAL ANALYSIS
  • 5.7 INDICATIVE PRICING
    • TABLE 8 SELLING PRICE OF STERILITY TESTING PRODUCTS
  • 5.8 PATENT ANALYSIS
    • FIGURE 19 STERILITY TESTING MARKET: PATENT TESTING APPLICATIONS (JANUARY 2012-DECEMBER 2022)
  • 5.9 ECOSYSTEM ANALYSIS
    • TABLE 9 STERILITY TESTING MARKET: SUPPLY CHAIN ECOSYSTEM
  • 5.10 KEY CONFERENCES AND EVENTS, 2023-2024
    • TABLE 10 STERILITY TESTING MARKET: CONFERENCES AND EVENTS (2023-2024)
  • 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR STERILITY TESTING PRODUCTS
    • 5.11.2 STERILITY TESTING MARKET: BUYING CRITERIA
    • FIGURE 21 KEY BUYING CRITERIA FOR END USERS
  • 5.12 TRADE ANALYSIS
    • TABLE 11 TOP 10 IMPORTERS OF MACHINERY AND APPARATUS FOR FILTERING/PURIFYING LIQUIDS (HS CODE - 842129)
    • TABLE 12 TOP 10 EXPORTERS OF MACHINERY AND APPARATUS FOR FILTERING/PURIFYING LIQUIDS (HS CODE - 842129)

6 STERILITY TESTING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 13 STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • 6.2 KITS & REAGENTS
    • 6.2.1 RISING DEMAND FOR STANDARD STERILITY TESTING TO DRIVE MARKET
    • TABLE 14 STERILITY TESTING MARKET FOR KITS & REAGENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 15 NORTH AMERICA: STERILITY TESTING MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 16 EUROPE: STERILITY TESTING MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 ASIA: STERILITY TESTING MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 18 REST OF THE WORLD: STERILITY TESTING MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 SERVICES
    • 6.3.1 GROWING TREND OF OUTSOURCING SERVICES TO CROS TO DRIVE MARKET
    • TABLE 19 STERILITY TESTING MARKET FOR SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 20 NORTH AMERICA: STERILITY TESTING MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 EUROPE: STERILITY TESTING MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 22 ASIA: STERILITY TESTING MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 23 REST OF THE WORLD: STERILITY TESTING MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 INSTRUMENTS
    • 6.4.1 INCREASING ADOPTION OF RAPID MICROBIAL METHODS TO SUPPORT MARKET GROWTH
    • TABLE 24 STERILITY TESTING MARKET FOR INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 25 NORTH AMERICA: STERILITY TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 26 EUROPE: STERILITY TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 27 ASIA: STERILITY TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 REST OF THE WORLD: STERILITY TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)

7 STERILITY TESTING MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
    • TABLE 29 STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
  • 7.2 MEMBRANE FILTRATION
    • 7.2.1 RISING DEMAND FOR TESTING OF DRUGS IN LIQUID DOSAGE FORMS TO FUEL ADOPTION
    • TABLE 30 STERILITY TESTING MARKET FOR MEMBRANE FILTRATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 31 NORTH AMERICA: STERILITY TESTING MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 32 EUROPE: STERILITY TESTING MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 33 ASIA: STERILITY TESTING MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 REST OF THE WORLD: STERILITY TESTING MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 DIRECT INOCULATION
    • 7.3.1 ABILITY TO PROVIDE TESTING FOR MICROBIAL CONTAMINANTS TO DRIVE MARKET
    • TABLE 35 STERILITY TESTING MARKET FOR DIRECT INOCULATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 36 NORTH AMERICA: STERILITY TESTING MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 EUROPE: STERILITY TESTING MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 ASIA: STERILITY TESTING MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 REST OF THE WORLD: STERILITY TESTING MARKET FOR DIRECT INOCULATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 OTHER TEST TYPES
    • TABLE 40 STERILITY TESTING MARKET FOR OTHER TEST TYPES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 41 NORTH AMERICA: STERILITY TESTING MARKET FOR KITS & REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 EUROPE: STERILITY TESTING MARKET FOR OTHER TEST TYPES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 ASIA: STERILITY TESTING MARKET FOR OTHER TEST TYPES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 REST OF THE WORLD: STERILITY TESTING MARKET FOR OTHER TEST TYPES, BY COUNTRY, 2021-2028 (USD MILLION)

8 STERILITY TESTING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 45 STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 PHARMACEUTICAL & BIOLOGICS MANUFACTURING
    • 8.2.1 GROWING PHARMACEUTICAL & BIOPHARMACEUTICAL PRODUCTION CAPACITIES TO DRIVE MARKET
    • TABLE 46 STERILITY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 47 NORTH AMERICA: STERILITY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 EUROPE: STERILITY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 ASIA: STERILITY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 REST OF THE WORLD: STERILITY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICS MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 MEDICAL DEVICE MANUFACTURING
    • 8.3.1 RISING DEMAND FOR STERILITY TESTING OF MEDICAL DEVICES TO DRIVE MARKET
    • TABLE 51 STERILITY TESTING MARKET FOR MEDICAL DEVICE MANUFACTURING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 52 NORTH AMERICA: STERILITY TESTING MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 53 EUROPE: STERILITY TESTING MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 ASIA: STERILITY TESTING MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 REST OF THE WORLD: STERILITY TESTING MARKET FOR MEDICAL DEVICE MANUFACTURING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 OTHER APPLICATIONS
    • TABLE 56 STERILITY TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 57 NORTH AMERICA: STERILITY TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 EUROPE: STERILITY TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 ASIA: STERILITY TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 REST OF THE WORLD: STERILITY TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 STERILITY TESTING MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 61 STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 PHARMACEUTICAL COMPANIES
    • 9.2.1 GROWING EXPANSION OF PRODUCTION CAPACITIES AND STRONG PIPELINE OF NOVEL DRUGS TO DRIVE MARKET
    • TABLE 62 STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 63 NORTH AMERICA: STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 EUROPE: STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 ASIA: STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 REST OF THE WORLD: STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 BIOTECHNOLOGY COMPANIES
    • 9.3.1 RISING R&D INVESTMENTS IN BIOTECH FIRMS TO DRIVE MARKET
    • TABLE 67 STERILITY TESTING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 68 NORTH AMERICA: STERILITY TESTING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: STERILITY TESTING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 ASIA: STERILITY TESTING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 REST OF THE WORLD: STERILITY TESTING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 OTHER END USERS
    • TABLE 72 STERILITY TESTING MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 73 NORTH AMERICA: STERILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 EUROPE: STERILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 ASIA: STERILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 76 REST OF THE WORLD: STERILITY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 STERILITY TESTING MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 77 STERILITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 22 NORTH AMERICA: STERILITY TESTING MARKET SNAPSHOT
    • TABLE 78 NORTH AMERICA: STERILITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 NORTH AMERICA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 80 NORTH AMERICA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 81 NORTH AMERICA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 82 NORTH AMERICA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Rising growth in medical devices industry to fuel uptake
    • TABLE 83 US: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 84 US: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 85 US: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 86 US: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Rising demand for pharmaceutical & biologics manufacturing to support market growth
    • TABLE 87 CANADA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 88 CANADA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 89 CANADA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 90 CANADA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    • TABLE 91 EUROPE: STERILITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 EUROPE: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 93 EUROPE: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 EUROPE: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 95 EUROPE: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Favorable R&D funding by federal & state governments to fuel uptake
    • TABLE 96 GERMANY: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 97 GERMANY: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 GERMANY: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 99 GERMANY: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Rising development of biotechnology manufacturing firms to drive market
    • TABLE 100 UK: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 101 UK: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 UK: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 103 UK: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Rising government initiatives for biologics manufacturing to support market growth
    • TABLE 104 FRANCE: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 105 FRANCE: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 FRANCE: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 107 FRANCE: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Favorable government support for establishment of biotech startups to support market growth
    • TABLE 108 ITALY: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 109 ITALY: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 110 ITALY: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 111 ITALY: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing focus on development of APIs to fuel uptake
    • TABLE 112 SPAIN: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 113 SPAIN: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 114 SPAIN: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 115 SPAIN: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 116 REST OF EUROPE: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 117 REST OF EUROPE: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 118 REST OF EUROPE: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 119 REST OF EUROPE: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 EUROPE: RECESSION IMPACT
  • 10.4 ASIA
    • FIGURE 23 ASIA: STERILITY TESTING MARKET SNAPSHOT
    • TABLE 120 ASIA: STERILITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 121 ASIA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 122 ASIA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 123 ASIA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 124 ASIA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 Favorable government policies to increase drug manufacturing to drive market
    • TABLE 125 CHINA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 126 CHINA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 127 CHINA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 128 CHINA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Rising investments for cell & gene therapy facilities to support market growth
    • TABLE 129 JAPAN: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 130 JAPAN: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 JAPAN: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 132 JAPAN: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Increasing demand for biosimilars to drive market
    • TABLE 133 INDIA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 134 INDIA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 135 INDIA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 136 INDIA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Significant exports of pharmaceutical drugs to fuel uptake of sterility testing services
    • TABLE 137 SOUTH KOREA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 138 SOUTH KOREA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 139 SOUTH KOREA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 140 SOUTH KOREA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 REST OF ASIA
    • TABLE 141 REST OF ASIA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 142 REST OF ASIA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 143 REST OF ASIA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 144 REST OF ASIA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 145 REST OF THE WORLD: STERILITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 146 REST OF THE WORLD: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 147 REST OF THE WORLD: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 148 REST OF THE WORLD: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 149 REST OF THE WORLD: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.1 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN
      • 10.5.1.1 Growing vaccine production to propel demand for sterility testing
    • TABLE 150 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 151 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 152 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 153 SOUTH & CENTRAL AMERICA AND THE CARIBBEAN: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 PACIFIC AND OCEANIA
      • 10.5.2.1 Improving investments in pharmaceutical R&D to fuel uptake
    • TABLE 154 PACIFIC AND OCEANIA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 155 PACIFIC AND OCEANIA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 PACIFIC AND OCEANIA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 157 PACIFIC AND OCEANIA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.3 AFRICA
      • 10.5.3.1 Favorable government support for healthcare infrastructure to drive market
    • TABLE 158 AFRICA: STERILITY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 159 AFRICA: STERILITY TESTING MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 AFRICA: STERILITY TESTING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 161 AFRICA: STERILITY TESTING MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • TABLE 162 STERILITY TESTING MARKET: KEY PLAYER STRATEGIES
  • 11.3 MARKET SHARE ANALYSIS
    • FIGURE 24 STERILITY TESTING MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS IN 2022 (LEADING FOUR COMPANIES)
    • TABLE 163 STERILITY TESTING MARKET: INTENSITY OF COMPETITIVE RIVALRY
  • 11.4 REVENUE SHARE ANALYSIS OF KEY PLAYERS
    • FIGURE 25 STERILITY TESTING MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS (TOP FOUR)
  • 11.5 COMPANY EVALUATION QUADRANT
    • FIGURE 26 STERILITY TESTING MARKET: COMPANY EVALUATION MATRIX (2022)
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
  • 11.6 COMPANY EVALUATION QUADRANT: STARTUPS/SMES
    • FIGURE 27 STERILITY TESTING MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
  • 11.7 COMPETITIVE BENCHMARKING
    • 11.7.1 COMPANY PRODUCT FOOTPRINT
    • TABLE 164 STERILITY TESTING MARKET: PRODUCT PORTFOLIO ANALYSIS
    • 11.7.2 COMPANY GEOGRAPHIC FOOTPRINT
    • TABLE 165 STERILITY TESTING MARKET: GEOGRAPHIC ANALYSIS
  • 11.8 COMPETITIVE SCENARIO
    • TABLE 166 STERILITY TESTING MARKET: DEALS (JANUARY 2019-JANUARY 2023)
    • TABLE 167 STERILITY TESTING MARKET: OTHER DEVELOPMENTS (JANUARY 2019-JANUARY 2023)

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS

(Business Overview, Products/Services Offered, Recent Developments, and MnM View)*

    • 12.1.1 MERCK KGAA
    • TABLE 168 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2021)
    • 12.1.2 CHARLES RIVER LABORATORIES
    • TABLE 169 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 29 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2021)
    • 12.1.3 BIOMERIEUX SA
    • TABLE 170 BIOMERIEUX SA: BUSINESS OVERVIEW
    • FIGURE 30 BIOMERIEUX SA: COMPANY SNAPSHOT (2021)
    • 12.1.4 SGS S.A.
    • TABLE 171 SGS SA: BUSINESS OVERVIEW
    • FIGURE 31 SGS S.A.: COMPANY SNAPSHOT (2021)
    • 12.1.5 SARTORIUS AG
    • TABLE 172 SARTORIUS AG: BUSINESS OVERVIEW
    • FIGURE 32 SARTORIUS AG: COMPANY SNAPSHOT (2022)
    • 12.1.6 THERMO FISHER SCIENTIFIC INC.
    • TABLE 173 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 33 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
    • 12.1.7 WUXI APPTEC
    • TABLE 174 WUXI APPTEC: BUSINESS OVERVIEW
    • 12.1.8 SAMSUNG BIOLOGICS
    • TABLE 175 SAMSUNG BIOLOGICS: BUSINESS OVERVIEW
    • FIGURE 34 SAMSUNG BIOLOGICS: COMPANY SNAPSHOT (2021)
    • 12.1.9 GENSCRIPT
    • TABLE 176 GENSCRIPT: BUSINESS OVERVIEW
    • FIGURE 35 GENSCRIPT: COMPANY SNAPSHOT (2021)
    • 12.1.10 PACIFIC BIOLABS
    • TABLE 177 PACIFIC BIOLABS: BUSINESS OVERVIEW
    • 12.1.11 NELSON LABORATORIES, LLC
    • TABLE 178 NELSON LABORATORIES, LLC: BUSINESS OVERVIEW
  • Business Overview, Products/Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 PACE ANALYTICAL
    • 12.2.2 RAPID MICRO BIOSYSTEMS, INC.
    • 12.2.3 TENTAMUS
    • 12.2.4 SINGOTA SOLUTIONS
    • 12.2.5 NEOPHARM LABS INC.
    • 12.2.6 LEXAMED
    • 12.2.7 ASTELL SCIENTIFIC LTD
    • 12.2.8 HIMEDIA LABORATORIES
    • 12.2.9 PALL CORPORATION (PART OF DANAHER CORPORATION)
    • 12.2.10 BOSTON ANALYTICAL
    • 12.2.11 SOLVIAS AG
    • 12.2.12 BD

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS